Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 380678, 12 pages
http://dx.doi.org/10.1155/2015/380678
Review Article

Safety of Chinese Herbal Medicine for Chronic Obstructive Pulmonary Disease

1Traditional & Complementary Medicine Research Program, School of Health Sciences and Health Innovations Research Institute (HIRi), RMIT University, Bundoora, Melbourne, VIC 3083, Australia
2Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
3The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
4Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China

Received 7 December 2014; Accepted 10 March 2015

Academic Editor: Chang-Gue Son

Copyright © 2015 Meaghan Coyle et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. George, L. L. Ioannides-Demos, N. M. Santamaria, D. C. M. Kong, and K. Stewart, “Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease,” Medical Journal of Australia, vol. 181, no. 5, pp. 248–251, 2004. View at Google Scholar · View at Scopus
  2. O. Abadoglu, E. Cakmak, and S. K. Demir, “The view of patients with asthma or chronic obstructive pulmonary disease (COPD) on complementary and alternative medicine,” Allergologia et Immunopathologia (Madr), vol. 36, no. 1, pp. 21–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Y. K. Chan and J. A. J. H. Critchley, “Usage and adverse effects of Chinese herbal medicines,” Human and Experimental Toxicology, vol. 15, no. 1, pp. 5–12, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. X. An, A. L. Zhang, A. W. Yang et al., “Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review,” Respiratory Medicine, vol. 105, no. 2, pp. 165–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. X. An, A. L. Zhang, B. H. May, L. Lin, Y. Xu, and C. C. Xue, “Oral Chinese herbal medicine improvement of quality of life for stable chronic obstructive pulmonary disease: a systematic review,” The Journal of Alternative and Complementary Medicine, vol. 18, no. 8, pp. 731–743, 2012. View at Google Scholar
  6. H. MacPherson and B. Liu, “The safety of Chinese herbal medicine: a pilot study for a national survey,” Journal of Alternative and Complementary Medicine, vol. 11, no. 4, pp. 617–626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Y. K. Chan, A. Y. W. Chan, and J. A. J. H. Critchley, “Hospital admissions due to adverse reactions to Chinese herbal medicines,” Journal of Tropical Medicine and Hygiene, vol. 95, no. 4, pp. 296–298, 1992. View at Google Scholar · View at Scopus
  8. J. T. Coon and E. Ernst, “Panax ginseng: a systematic review of adverse effects and drug interactions,” Drug Safety, vol. 25, no. 5, pp. 323–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Ernst, “Adverse effects of herbal drugs in dermatology,” British Journal of Dermatology, vol. 143, no. 5, pp. 923–929, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Guo, M. H. Pittler, and E. Ernst, “Herbal medicines for the treatmet of COPD: a systematic review,” European Respiratory Journal, vol. 28, no. 2, pp. 330–338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Bensoussan, S. P. Myers, and A.-L. Carlton, “Risks associated with the practice of traditional Chinese medicine: an Australian study,” Archives of Family Medicine, vol. 9, no. 10, pp. 1071–1078, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. Cochrane Airways Group, Developing a Search Strategy for an Airways Group Systematic Review, 2012, http://airways.cochrane.org/sites/airways.cochrane.org/files/uploads/Search%20methods%20guide%20V1.3.pdf.
  13. H. Che, J. Pang, C. Li, and Y. Wang, “Effects of Zhike Qingfei oral liquid on inflammatory cells, interleukin-8 and tumour necrosis factor-a in the sputum in 25 cases of chronic obstructive pulmonary diseases,” Journal of Traditional Chinese Medicine, vol. 46, no. 10, pp. 759–761, 2005. View at Google Scholar
  14. H. Che, J. Pang, and C. Li, “Effects of Zhike Qingfei oral liquid on inflammatory cells, interleukin-8 and tumour necrosis factor-a in the sputum in 25 cases of chronic obstructive pulmonary diseases,” Journal of Traditional Chinese Medicine, vol. 46, no. 10, pp. 759–761, 2005. View at Google Scholar
  15. F. Cui, “Modified Ma Xing Shi Gan Tang in combination with continuous positive airway pressure for acute exacerbation of chronic pulmonary disease, 35 cases,” Henan Traditional Chinese Medicine, vol. 33, no. 2, pp. 183–184, 2013. View at Google Scholar
  16. G. Dong, Z. Zhang, C. Li, and C. Han, “Clinical observation of 120 cases of Xi Xin Nao injections for chronic pulmonary disease,” Journal of Binzhou Medical University, vol. 31, no. 2, pp. 141–142, 2008. View at Google Scholar
  17. Z. Fu, The Effect of Tonify Spleen, Remove Phlegm and Invigorate Blood Method on the Lung Function and Qualify of Life for Stable Stage of Chronic Pulmonary Disease, Guangzhou University of Chinese Medicine, 2008.
  18. G. Gong, “Combined therapy of Chinese medicine and western medicine for the treatment of COPD in the elderly,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 17, no. 36, pp. 5595–5596, 2008. View at Google Scholar
  19. L. Guo and X. Xu, “Clinical observation of the effect of Tan re qing injections for AECOPD treatment,” Journal of Clinical Pulmonary Medicine, vol. 10, no. 6, pp. 803–804, 2005. View at Google Scholar
  20. Y. Guo, The Clinical Observation of Tonify Qi and Invigorate Blood Method for the Treatment of AECOPD Patients with Qi Deficiency and Blood Stasis, Shandong University of Traditional Chinese Medicine, 2011.
  21. G. Han and S. Zhang, “The effect of removing turbidity and stasis method in the treatment of acute exacerbation of chronic pulmonary disease,” Beijing University of Traditional Chinese Medicine, vol. 30, no. 2, pp. 94–96, 2011. View at Google Scholar
  22. Y. Hu and C. Yang, “Combined therapy of Chinese medicine and Western medicine treatment in acute exacerbation of chronic pulmonary disease,” Journal of Practical Traditional Chinese Medicine, vol. 26, no. 10, pp. 698–699, 2010. View at Google Scholar
  23. Z.-Q. Hua and Y.-J. Chang, “Clinical study of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease (AECOPD),” China Journal of Chinese Materia Medica, vol. 38, no. 3, pp. 440–442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Huang, Q. Huang, D. Lu, and C. Xie, “Clinical study of Tanreqing injections for acute exacerbation in chronic pulmonary disease,” Journal of Emergency in Traditional Chinese Medicine, vol. 15, no. 5, pp. 464–466, 2006. View at Google Scholar
  25. D. H. Huang, L. Wu, D. He, and L. Lin, “Clinical observation of tranquilization period of chronic obstructive pulmonary disease treated by integration of traditional Chinese medicine and Western medicine,” Journal of the Fourth Military Medical University, vol. 26, no. 17, pp. 1611–1613, 2005. View at Google Scholar
  26. H. Ji, G. Hu, J. Gao, and S. Wang, “Clinical observation of Tonify Qi and Yin method for stable chronic pulmonary disease patients with malnutrition,” Shandong Journal of Chinese Medicine, vol. 22, no. 1, pp. 11–12, 2003. View at Google Scholar
  27. D. Li, Clinical Study of Modified Xuan Bai Cheng Qi Tang for Chronic Pulmonary Disease, Liaoning University of Chinese Medicine, 2009.
  28. F. Li, “The treatment effect of combined Chinese medicine and Western medicine for acute exacerbation of chronic pulmonary disease in the elderly,” Chinese Health Care, vol. 17, no. 18, pp. 716–717, 2009. View at Google Scholar
  29. S.-Y. Li, J.-S. Li, M.-H. Wang et al., “Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study,” BMC Complementary and Alternative Medicine, vol. 12, article 197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Li, S. Zhang, and L. Shu, “35 cases of Shenha capsules for the treatment of COPD patients with Lung and Kidney deficiency plus phlegm obstruction,” Guiding Journal of Traditional Chinese Medicine and Pharmacy, vol. 17, no. 12, pp. 45–46, 2011. View at Google Scholar
  31. P. Li, “The effects of combined therapy of Chinese and Western medicine for the treatment of COPD, 68 cases,” Guang Ming Chinese Medicine, vol. 25, no. 5, p. 845, 2010. View at Google Scholar
  32. A. Liang, The Effect of Tonify Lung, Spleen and Kidney Method on Patients Quality of Life in Chronic Pulmonary Disease, Beijing University of Chinese Medicine, 2009.
  33. J. Liu, “Observation of the therapeutic effect of Tanreqing injection on obstructive pulmonary emphysema,” Pharmacology and Clinics of Chinese Materia Medica, vol. 28, no. 2, pp. 170–172, 2012. View at Google Scholar
  34. W. Liu, “Combine therapy using syndrome differentiation and western medicine for the treatment of servere COPD, 32 cases,” Shanxi Journal of Chinese Medicine, vol. 32, no. 6, pp. 702–704, 2011. View at Google Scholar
  35. X. Liu, M. Tu, W. Liu, H. Lei, and G. Luo, “The effect of Tanreqing injections for acute exacerbation of COPD,” Clinical Medicine, vol. 25, no. 9, pp. 60–61, 2005. View at Google Scholar
  36. Y. Liu, “Combined therapy of Jin Shui Bao capsules and Western medicine for the treatment of acute exacerbation of chronic pulmonary disease, 43 cases,” Journal of Practical Traditional Chinese Medicine, vol. 22, no. 4, pp. 224–225, 2006. View at Google Scholar
  37. X. Ma and H. Li, “A study of tanreqing plus levofloxacin fot the treatment of acute exacerbation of chronic pulmonary disease,” Guide of China Medicine, vol. 7, no. 18, pp. 69–70, 2009. View at Google Scholar
  38. Z. Ming, L. Yu, L. Wang, and Y. Lv, “Effects of Xuebing injection on the clinical efficacy of noninvasive ventilation in patients with chronic obstructive pulmonary disease,” Journal of Emergency in Traditional Chinese Medicine, vol. 17, no. 8, pp. 1047–1049, 2008. View at Google Scholar
  39. K. Mukaida, N. Hattori, K. Kondo et al., “A pilot study of the multiherb Kampo medicine bakumondoto for cough in patients with chronic obstructive pulmonary disease,” Phytomedicine, vol. 18, no. 8-9, pp. 625–629, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Ou and J. Huang, “Analyze the effect of Chinese and Western medicine combination for acute attack of chronic obstructive pulmonary emphysema,” The Journal of Medical Theory and Practice, vol. 25, no. 15, pp. 1817–1818, 2012. View at Google Scholar
  41. W. Peng, “Clinical observation of Tan Re Qing injection for the treatment of acute exacerbation of COPD, 87 cases,” Asia Pacific Traditional Medicine, vol. 4, no. 11, pp. 67–68, 2008. View at Google Scholar
  42. Y. Shen, “Clinical observation of inhaled ipratropium bromide plus Gu ben ke chuan pills for the treatment of chronic obstructive pulmonary disease,” China Modern Medicine, vol. 17, no. 34, pp. 63–65, 2010. View at Google Scholar
  43. W. Tong, Y. Cao, and A. Zhuo, “The clinical observation of Xiao ke chuan capsules plus tiotropium bromide for the treatment of stable chronic obstructive pulmonary disease (aboe stage 3) in the elderly,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 19, no. 3, pp. 79–80, 2012. View at Google Scholar
  44. L. Wu, L. Lin, Y. Xu et al., “Clinical research on 178 cases of chronic obstructive pulmonary disease in the stable stage treated with Jianpi Yifei II,” Journal of Traditional Chinese Medicine, vol. 52, no. 17, pp. 1465–1468, 2011. View at Google Scholar
  45. C. Xiong, M. Zou, J. Zhang, and H. Xiao, “Integrated traditional and western treatment of chronic obstructive pulmonary disease with acute exacerbation of the effect,” Chinese and Foreign Medical Research, vol. 9, no. 24, pp. 11–12, 2011. View at Google Scholar
  46. X. Yang, “The effect of Tanreqing injection in the treatment of acute exacerbation of chronic obstructive pulmonary disease,” Health Horizon Medical Science Fascicule, vol. 2, p. 82, 2006. View at Google Scholar
  47. Y. Yuan, Y. Deng, and Y. Hu, “Clinical observation of Sang bai pi tang for the treatment of AECOPD patients with Phlegm heat obstructing the Lung syndrome,” Journal of Sichuan of Traditional Chinese Medicine, vol. 29, no. 11, p. 81, 2011. View at Google Scholar
  48. C. Ye, H. Xue, B. Fu et al., “The clinical study of Bu-yuan decoction interfering in the chronic obsttructive pulmonary disease in stable phase,” Journal of Jiangxi University of TCM, vol. 22, no. 1, pp. 54–57, 2010. View at Google Scholar
  49. B. You, Clinical Research of the Effect of Yi Fei He Ji on the Quality of Life for COPD Patients, Hunan University of Traditional Chinese Medicine, 2007.
  50. R. Zhai and H. Zhai, “Clinical study of Fu Zheng Qing Tan Hua Yu capsules for the treatment of stable chronic obstructive pulmonary disease,” Journal of Practical Traditional Chinese Medicine, vol. 28, no. 11, pp. 900–902, 2012. View at Google Scholar
  51. L. Zhang and J. Wu, “Effect of Suzi Jiangqi decoction combined with Western medicine on acute exacerbation of chronic obstructive pulmonary disease,” Chinese Medicine Modern Distance Education of China, vol. 9, no. 15, pp. 48–49, 2011. View at Google Scholar
  52. Y. Zhang, T. Li, G. Wang et al., “Randomized controlled trial of TanReqing injection in treatment of acute exacerbation of chronic obstructive pulmonary disease (syndrome of retention of phlegm-heat in the lung),” Chinese Journal of Evidence-Based Medicine, vol. 4, no. 5, pp. 300–305, 2004. View at Google Scholar
  53. W. Zhao and Z. Liu, “The efficacy of integrated traditional Chinese medicine and western medicine for treatment of patients with acute exacerbation of chronic obstructive pulmonary disease,” Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, vol. 19, no. 4, pp. 232–234, 2012. View at Google Scholar
  54. H. Zheng, Clinical observation of Qingfei Bushen method on treating chronic obstructive pulmonary disease in acute exacerbation [M.S. thesis], Shandong University of Traditional Chinese Medicine, 2012.
  55. X. Zheng, C. Chen, Q. Chen, and Y. Wang, “Clinical observation of Yi Xin Kang Tai capsules for chronic obstructive pulmonary disease,” Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine, vol. 3, no. 3, p. 15, 2003. View at Google Scholar
  56. H. Zhong, S. Peng, Y. Luo, H. Gao, S. Ao, and J. Wang, “The clinical effect of Feishu capsule on steady stage of COPD,” Tianjin Medical Journal, vol. 38, no. 10, pp. 849–851, 2010. View at Google Scholar
  57. J. Zhou, B. Wu, and F. Cai, “The effect of Tanreqing plus Lomefloxacin in the treatment of acute exacerbation of chronic pulmonary disease in the elderly,” China Foreign Medical Treatment, vol. 23, p. 73, 2008. View at Google Scholar
  58. X. Zhang and D. Cheng, “The impact of Liu jun zi wan (pills) for BODE index in stable COPD,” Yunnan Journal of Traditional Chinese Medicine and Materia Medica, vol. 29, no. 8, pp. 8–9, 2008. View at Google Scholar
  59. Y. Zhang, “Clinical observation of modified Yang he tang (decoction) for COPD,” Chinese Journal of Modern Drug Application, vol. 4, no. 5, pp. 123–124, 2010. View at Google Scholar
  60. D. Gross, Z. Shenkman, B. Bleiberg, M. Dayan, M. Gittelson, and R. Efrat, “Ginseng improves pulmonary functions and exercise capacity in patients with COPD,” Monaldi Archives for Chest Disease—Pulmonary Series, vol. 57, no. 5-6, pp. 242–246, 2002. View at Google Scholar · View at Scopus
  61. X. Zhang, T. Yin, X. Yang, H. Wu, and J. Yao, “Effect of Lifei Yishen-recipe on lung function of COPD Grade III,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, no. 2, pp. 289–290, 2013. View at Google Scholar
  62. W. Xue, “Observation of combined therapy of Chinese medicine and Western medicine for chronic obstructive pulmonary disease,” Guang Ming Chinese Medicine, vol. 27, no. 8, pp. 1622–1623, 2012. View at Google Scholar
  63. S. Liu, “Acute exacerbations of chronic obstructive pulmonary disease treated by integrated traditional Chinese and western medicine,” Clinical Medical Engineering, vol. 18, no. 3, pp. 371–372, 2011. View at Google Scholar
  64. H. MacPherson, A. White, and A. Bensoussan, “The safety of acupuncture,” in Acupuncture Research: Strategies for Establishing an Evidence Base, H. MacPherson, Ed., pp. 57–76, Churchill Livingstone, Philadelphia, Pa, USA, 2008. View at Google Scholar
  65. Global Initiative for Chronic Obstructive Lung Disease, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease, 2013.
  66. D. M. Newnham, “Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing,” Drug Safety, vol. 24, no. 14, pp. 1065–1080, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Pinn, “Adverse effects associated with herbal medicine,” Australian Family Physician, vol. 30, no. 11, pp. 1070–1075, 2001. View at Google Scholar · View at Scopus
  68. C. W. Cheng, Z. X. Bian, Y. P. Li et al., “Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials,” Journal of Chinese Integrative Medicine, vol. 6, no. 9, pp. 881–886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. A. White, “A cumulative review of the range and incidence of significant adverse events associated with acupuncture,” Acupuncture in Medicine, vol. 22, no. 3, pp. 122–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. K. Loke, D. Price, and A. Herxheimer, “Systematic reviews of adverse effects: framework for a structured approach,” BMC Medical Research Methodology, vol. 7, article 32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. J. P. A. Ioannidis, S. J. W. Evans, P. C. Gøtzsche et al., “Better reporting of harms in randomized trials: an extension of the CONSORT statement,” Annals of Internal Medicine, vol. 141, no. 10, pp. 781–788, 2004. View at Publisher · View at Google Scholar · View at Scopus